Browsing: health technology assessment

The European Commission has adopted an implementing regulation for joint scientific consultations on medical devices and in vitro diagnostic medical devices under the Health Technology Assessment (HTA) Regulation.

The European Union has initiated its first joint clinical assessments for medicinal products under the Health Technology Assessment Regulation (EU 2021/2282), focusing on treatments for paediatric cancer and advanced skin cancer therapy.

A collaboration between health technology assessment (HTA) bodies in the US, Canada, and England will investigate how non-traditional benefits, like the value of hope and scientific spillover, can inform appraisals and understandings of a product’s value.

EUCOPE’s Alexander Natz highlights the value of early engagement with national agencies for companies unable to participate in joint scientific consultations under the EU Health Technology Assessment Regulation.

The European Health Data Space (EHDS) promises to revolutionize health technology assessment, especially in the digital health sector, by providing real-world evidence and capturing patient-reported outcomes.

The European Health Data Space (EHDS) is poised to revolutionize health technology assessment, particularly in the digital health sector, by providing real-world evidence and patient-reported outcomes.

Trinity Life Sciences has upgraded its HTA Vision offering, integrating generative AI to expedite the extraction and summarization of data from health technology assessments, providing life sciences leaders with crucial market insights and expert analysis.

Trinity Life Sciences has upgraded its HTA Vision offering to streamline information extraction from health technology assessments using generative AI.

Union Health Minister JP Nadda emphasizes the government’s commitment to accessible and affordable healthcare.

This research examines the implementation and development of Hospital-Based Health Technology Assessment (HB-HTA) in Poland from the perspective of hospital representatives. It analyzes the benefits and barriers of implementing HB-HTA, offering insights into the challenges and opportunities for improving health technology evaluation in Polish hospitals.